ES/IODE @esiode.bsky.social · 2h📃Scientific paper: Knowledge and perceptions of Australian postgraduate veterinary students prior to formal education of antimicrobial use and antimicrobial resistance Ref.: Elsevier, 2021 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 3h📃Scientific paper: Investigation of the causal relationship between ALS and autoimmune disorders: a Mendelian randomization study Ref.: BioMed Central, 2022 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 4h📃Scientific paper: Fatal eosinophilic myocarditis and submassive hepatic necrosis in lamotrigine induced DRESS syndrome Ref.: BioMed Central, 2023 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 5h📃Scientific paper: Ersteinschätzung urologischer Notfälle am Beispiel einer Schwerpunktklinik Ref.: Springer, 2025 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 6h📃Scientific paper: Relationship of serum iron and thyroid hormone in obesity and after laparoscopic sleeve gastrectomy Ref.: BioMed Central, 2024 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 8h📃Scientific paper: Modelling the delayed shock-breakout emission following jet-launching binary neutron star mergers via relativistic magnetohydrodynamic simulations simulations Ref.: arXiv, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 9h📃Scientific paper: The antecedents and consequences of stereotype threat in Parkinson's disease Ref.: John Wiley and Sons Inc., 2022 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 10h📃Scientific paper: The Future of Attention Models: Convergence of Deep Learning with Artificial and Human Attention Ref.: Springer, 2025 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 11h📃Scientific paper: A systematic review on fungal community composition in rhizosphere soils from plants in Arid and Semi-Arid regions Ref.: Springer, 2026 ➡️ Continued on ES/IODE 011
ES/IODE @esiode.bsky.social · 12h📃Scientific paper: Impact of educational interventions on the prevention of influenza: A systematic review Ref.: Frontiers Media S.A., 2022 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 13h📃Scientific paper: Characteristics of molecular epidemiology and transmitted drug resistance among newly diagnosed HIV-1 infections in Lishui, China from 2020 to 2023 Ref.: BioMed Central, 2025 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 15h📃Scientific paper: Rebooting Microreboot: Architectural Support for Safe, Parallel Recovery in Microservice Systems Ref.: arXiv, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 16h📃Scientific paper: Novel Development of LLM Driven mCODE Data Model for Improved Clinical Trial Matching to Enable Standardization and Interoperability in Oncology Research Ref.: arXiv, 2024 ➡️ Continued on ES/IODE 010
ES/IODE @esiode.bsky.social · 17h📃Scientific paper: An optimal control problem for anti-inflammatory treatments of Alzheimer's disease Ref.: CCSD, 2025 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: SUMOylation Regulates TDP-43 Splicing Activity and Nucleocytoplasmic Distribution Ref.: Springer, 2021 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: Global disparities in availability of epinephrine auto-injectors Ref.: World Allergy Organization, 2023 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: Pediatric Nephrolithiasis Ref.: Springer, 2025 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: Not Only Grey Matter: OmniBrain for Robust Multimodal Classification of Alzheimer's Disease Ref.: arXiv, 2025 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: Prognostic factors and prognostic risk score of 30-day all-cause mortality in thyroid storm Ref.: BMC, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: Poster 130. Similar Hip-RSI Scores in Active Patients First Year After Hip Impingement vs Hip Dysplasia Surgery Ref.: SAGE Publications, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: Gaia21bja: pre-main sequence star with quasi-periodic bursts Ref.: arXiv, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: The Endotoxin Hypothesis of Parkinson's Disease Ref.: John Wiley & Sons, Inc., 2023 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: Arterial Drug Delivery in the Future: Addressing Complex Problems as Acute Ischemic Stroke Ref.: Springer, 2025 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: Introduction to Fungi in Wastewater Treatment and Fundamentals of Mycology and Wastewater Chemistry Ref.: Springer, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: Bidirectional movement of emerging H5N8 Avian Influenza Viruses between Europe and Asia via migratory birds since early 2020 Ref.: HAL CCSD;Oxford University Press (OUP), 2023 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: Mpox in people living with and without HIV, including people on PrEP, during a multistate outbreak in Spain in 2022 Ref.: Nature, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: Agentic Jackal: Live Execution and Semantic Value Grounding for Text-to-JQL Ref.: arXiv, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 01/10/2026📃Scientific paper: A phase 2 study of tislelizumab combined with bevacizumab and chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer Ref.: Elsevier, 2025 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 30/09/2026📃Scientific paper: Protein clearance strategies for disease intervention Ref.: Springer, 2022 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 30/09/2026📃Scientific paper: Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study Ref.: BioMed Central, 2024 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 30/09/2026📃Scientific paper: AI-Augmented Thyroid Scintigraphy for Robust Classification of Disease Ref.: arXiv, 2025 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 30/09/2026📃Scientific paper: Nonuniform Particle Injection into Black Hole Jets by Radiative Magnetic Reconnection Ref.: arXiv, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 30/09/2026📃Scientific paper: Do-it-yourself laboratory information management system: customizing a simple sample processing database for a low-tech, high-throughput symbiosis laboratory Ref.: Springer, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 30/09/2026📃Scientific paper: Potential impacts of prolonged absence of influenza virus circulation on subsequent epidemics Ref.: Cold Spring Harbor Laboratory, 2022 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 30/09/2026📃Scientific paper: OncoTriad-QA: A Patient-Level Radiology-Pathology-Genomics Benchmark for Pan-Cancer Reasoning Ref.: arXiv, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 30/09/2026📃Scientific paper: Radiogenomic Bipartite Graph Representation Learning for Alzheimer's Disease Detection Ref.: arXiv, 2025 ➡️ Continued on ES/IODE 001
ES/IODE @esiode.bsky.social · 29/09/2026📃Scientific paper: Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study Ref.: Springer, 2024 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 29/09/2026📃Scientific paper: Penicillin allergy de-labeling: Adaptation of risk stratification tool for patients and families() Ref.: World Allergy Organization, 2024 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 29/09/2026📃Scientific paper: Calibrated Selective Prediction Using Deep Ensembles for ROI-Based Thyroid Nodule Ultrasound Classification Under Dataset Shift: A Retrospective Evaluation Ref.: arXiv, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 29/09/2026📃Scientific paper: Magnetized Coulomb crystals in neutron star crusts Ref.: arXiv, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 29/09/2026📃Scientific paper: Comparison of One- Two- and Three- Dimensional CNN models for Drawing-Test-Based Diagnostics of the Parkinson's Disease Ref.: arXiv, 2023 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 29/09/2026📃Scientific paper: The Scientific Exploration of Ketamine’s Future Role in Anesthesia Ref.: Springer, 2025 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 29/09/2026📃Scientific paper: The Changing Face of Candida in Southeast Asia Ref.: Springer, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 29/09/2026📃Scientific paper: Cangma Huadu granules, a new drug with great potential to treat coronavirus and influenza infections, exert its efficacy through anti-inflammatory and immune regulation Ref.: Elsevier B.V., 2022 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 29/09/2026📃Scientific paper: Telehealth Care for Adolescents and Young Adults with HIV: Practices and Perspectives from a National Mixed-Methods Study of U.S. HIV Care Providers Ref.: Cold Spring Harbor Laboratory, 2025 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 29/09/2026📃Scientific paper: SCPatcher: Automated Smart Contract Code Repair via Retrieval-Augmented Generation and Knowledge Graph Ref.: arXiv, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 29/09/2026📃Scientific paper: An Integrated Deep Learning Model for Skin Cancer Detection Using Hybrid Feature Fusion Technique Ref.: arXiv, 2024 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 29/09/2026📃Scientific paper: MedOrch: Medical Diagnosis with Tool-Augmented Reasoning Agents for Flexible Extensibility Ref.: arXiv, 2025 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 28/09/2026📃Scientific paper: V-REX: Efficient Specialist VLM Training for Veterinary X-Rays Ref.: arXiv, 2026 ➡️ Continued on ES/IODE 000
ES/IODE @esiode.bsky.social · 28/09/2026📃Scientific paper: The aggressive face of melasma: unveiling the influence of upper lip pigmentation on social perception Ref.: Termedia Publishing House, 2024 ➡️ Continued on ES/IODE 000